Apyx Medical Inc (APYX) Stock Forecast & Price Target
Apyx Medical Inc · NASDAQ
$3.85-0.07 (-1.79%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Apyx Medical Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $6.00 to $8.00, so the covering firms are broadly aligned. The average target of $6.60 sits 71% above the current $3.85. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees revenue growth near 13% this year and 10% next, consensus EPS building from about $-0.09 next quarter toward $-0.25 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Apyx Medical Inc.
As of Jul, 5 of 5 firms rate APYX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
APYX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.09
Range $-0.12 – $-0.06 · 5 analysts · +76% YoY
Next period, 5 analysts expect Apyx Medical Inc to earn $-0.09 a share (range $-0.12 – $-0.06), versus $-0.05 a year earlier. Full-year consensus is $-0.27, growing to $-0.25 the year after.
REVENUE · NEXT QUARTER
$13.7M
Range $12.9M – $14.1M · 5 analysts · +6% YoY
Revenue is expected to reach $13.7M (range $12.9M – $14.1M), +6.0% year-over-year. Full-year consensus is $59.6M, rising to $66.1M next year.
Top analysts covering Apyx Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on APYX.
#1
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$7.00+81.8% to target
Overall win rate
34%
+ Follow
#2
David Turkaly
JMP Securities · Rank #276
Buy
$8.00+107.8% to target
Overall win rate
31%
+ Follow
#3
SE
Sam Eiber
BTIG
Buy
$6.00+55.8% to target
Coverage
—
+ Follow
#4
MH
Matthew Hewitt
Craig-Hallum
Buy
$6.00+55.8% to target
Coverage
—
+ Follow
#5
KB
Kyle Bauser
Roth Capital
Buy
$6.00+55.8% to target
Coverage
—
+ Follow
APYX stock forecast FAQ
What is APYX's average 12-month price target?+
The 5 analysts with a live target average $6.60 for Apyx Medical Inc over the next 12 months, ranging from a $8.00 high to a $6.00 low.
Is APYX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for APYX?+
The Street-high target is $8.00 (Citizens), and the Street-low is $6.00 (Craig-Hallum). The average of all 5 active targets is $6.60.
How many Wall Street analysts cover APYX?+
5 analysts have an active rating on Apyx Medical Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering APYX?+
Among analysts who currently cover APYX, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #238). Their current call is Buy with a $7.00 target.
What is Apyx Medical Inc's projected EPS for next quarter?+
The consensus estimate is $-0.09 per share (range $-0.12 – $-0.06) across 5 analysts. Full-year EPS is projected at $-0.27, rising to $-0.25 the following year.
How much revenue is Apyx Medical Inc expected to report next quarter?+
Consensus revenue is $13.7M (range $12.9M – $14.1M). Full-year revenue is projected at $59.6M, growing to $66.1M next year.
Have analysts been upgrading or downgrading APYX lately?+
As of Jul, 5 of 5 firms rate APYX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their APYX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
